{"result": "{\n    \"title\": \"Belgian Medical Study Network on Septic Shock Prevention\",\n    \"summary\": \"This report focuses on a network of Belgian hospitals and research entities involved in the HYPRESS study, a significant medical research initiative aimed at preventing septic shock. The network includes St. Elisabeth Hospital, Erasme University Hospital, Centre Hospitalier Universitaire de Charleroi, and Université Libre de Bruxelles, all located in Belgium, and collaborates with pharmaceutical companies and statistical experts.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the potential global health implications of the HYPRESS study's findings on septic shock prevention.\",\n    \"findings\": [\n        {\n            \"summary\": \"Central role of Belgian hospitals in the HYPRESS study\",\n            \"explanation\": \"St. Elisabeth Hospital, Erasme University Hospital, and Centre Hospitalier Universitaire de Charleroi are key entities in the Belgian medical community, all participating in the HYPRESS study. These hospitals are not only pivotal in patient enrollment and data collection but also serve as a bridge between academic research and clinical application. Their collaboration underscores Belgium's commitment to advancing medical research and patient care in critical conditions like septic shock [Data: Entities (230, 233, 235); Relationships (489, 492, 495)].\"\n        },\n        {\n            \"summary\": \"Collaboration with pharmaceutical companies for medical supplies\",\n            \"explanation\": \"The HYPRESS study's success relies on the support from pharmaceutical companies such as Rotexmedica and Roche Diagnostics, which supplied essential medical products like hydrocortisone vials and cortisol assays, respectively. This collaboration highlights the importance of industry partnerships in clinical research, ensuring that the necessary tools and medications are available for comprehensive studies. Such partnerships are crucial for the logistical execution of large-scale medical trials [Data: Entities (332, 336); Relationships (540, 543)].\"\n        },\n        {\n            \"summary\": \"Statistical analysis and methodology\",\n            \"explanation\": \"The HYPRESS study employs rigorous statistical analysis, with contributions from independent statisticians and the use of advanced statistical methods like the Lan-DeMets and O'Brien-Fleming approaches. These methodologies ensure the scientific integrity and reliability of the study's findings. The involvement of Université Libre de Bruxelles and the Clinical Trial Centre Leipzig in biostatistical analysis and data management further underscores the study's commitment to methodological excellence [Data: Entities (240, 254); Relationships (531, 576)].\"\n        },\n        {\n            \"summary\": \"International cooperation and knowledge sharing\",\n            \"explanation\": \"While the HYPRESS study is primarily based in Belgium, it also reflects a broader pattern of international cooperation in medical research. The study's support from the German Federal Ministry of Education and Research, along with the cooperation of the German Sepsis Competence Network, exemplifies how cross-border collaborations can enhance the scope and impact of research. This international aspect is crucial for pooling resources, knowledge, and expertise to tackle global health challenges [Data: Entities (251, 252, 253); Relationships (505, 506)].\"\n        },\n        {\n            \"summary\": \"Impact on global health policies and practices\",\n            \"explanation\": \"The findings of the HYPRESS study have the potential to influence global health policies and clinical practices regarding the treatment of septic shock. By investigating the efficacy of hydrocortisone in preventing the progression to shock in patients with severe sepsis, the study addresses a critical gap in current medical knowledge. The collaboration between hospitals, universities, and pharmaceutical companies, supported by rigorous statistical analysis, sets a precedent for future research in critical care medicine [Data: Entities (251); Relationships (505, 540, 543)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n230,ST. ELISABETH HOSPITAL,A hospital located in Brussels involved in a medical study,4\n245,BELGIUM,\"Country where St. Elisabeth Hospital, Erasme University Hospital, Centre Hospitalier Universitaire de Charleroi, and Université Libre de Bruxelles are located\",4\n233,ERASME UNIVERSITY HOSPITAL,A hospital located in Brussels involved in a medical study and the workplace of C. Mélot,3\n235,CENTRE HOSPITALIER UNIVERSITAIRE DE CHARLEROI,\"A hospital located in Charleroi, Belgium involved in a medical study\",3\n240,UNIVERSITÉ LIBRE DE BRUXELLES,University in Brussels where H. Njimi works as a trial statistician,3\n242,BRUSSELS,\"Location of St. Elisabeth Hospital, Erasme University Hospital, and Université Libre de Bruxelles\",3\n331,ICUS,Intensive Care Units participating in the study where patients were hospitalized and enrolled based on eligibility criteria,4\n332,ROTEXMEDICA,Pharmaceutical company that prepared hydrocortisone vials used in the study,2\n336,ROCHE DIAGNOSTICS,Company whose Elecsys cortisol assay was used for measuring cortisol levels in the study,2\n335,ALLIANCE,Pharmaceutical company mentioned as a provider of cosyntropin for the corticotropin test,1\n251,HYPRESS STUDY,\"The Hydrocortisone for Prevention of Septic Shock (HYPRESS) study is an investigator-initiated, multicenter, placebo-controlled, double-blind RCT supported by the German Federal Ministry of Education and Research, conducted in cooperation with the German Sepsis Competence Network and the Clinical Trial Centre Leipzig\",4\n255,BAG HEALTH CARE GMBH,No Description,1\n312,BASE-LINE CHARACTERISTICS,Initial conditions or attributes of patients measured at the beginning of the study,4\n313,VITAL SIGNS,Measurements of the body's most basic functions used to assess the general physical health of a person,1\n314,RESUSCITATION END POINTS,Specific goals set for the resuscitation of patients in the study,1\n315,ORGAN-DYSFUNCTION SCORES,Quantitative measures used to assess the severity of organ dysfunction in patients,1\n316,COAGULATION-RELATED VARIABLES,\"Variables related to the blood's ability to clot, assessed as part of the study\",1\n254,CLINICAL TRIAL CENTRE LEIPZIG,\"Provides internet-based randomization, data capture, biostatistical analysis, and pharmacovigilance for the HYPRESS study\",1\n252,GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH,\"Supports the HYPRESS study, which investigates the effects of hydrocortisone on preventing progression to shock in patients with severe sepsis\",1\n253,GERMAN SEPSIS COMPETENCE NETWORK (SEPNET),\"Cooperates in the HYPRESS study, which is focused on the prevention of septic shock through the administration of hydrocortisone\",1\n334,NOVARTIS,Pharmaceutical company that provided cosyntropin for the corticotropin test in the study,1\n236,J. RICO,\"Associated with Rio Hortega University Hospital in Valladolid, Spain for a medical study\",1\n238,RIO HORTEGA UNIVERSITY HOSPITAL,\"A hospital located in Valladolid, Spain involved in a medical study\",4\n237,J.I. GOMEZ HERRERAS,\"Associated with Rio Hortega University Hospital in Valladolid, Spain for a medical study\",1\n232,M. VAN NUFFELEN,Associated with St. Elisabeth Hospital in Brussels for a medical study,1\n244,VALLADOLID,Location of Rio Hortega University Hospital,1\n246,SPAIN,No Description,1\n231,S. BRIMIOULLE,Associated with St. Elisabeth Hospital in Brussels for a medical study,1\n241,C. MÉLOT,Independent statistician and physician at Erasme University Hospital in Brussels responsible for conducting sequential analysis and evaluation of serious adverse effects,1\n243,CHARLEROI,Location of Centre Hospitalier Universitaire de Charleroi,1\n234,M. VANCUTSEM,\"Associated with Centre Hospitalier Universitaire de Charleroi in Charleroi, Belgium for a medical study\",1\n308,CHI-SQUARE TEST,A statistical test used to compare observed results with expected results,1\n310,DEMET'S AND LAN,Developers of the alpha spending function used in statistical analysis to adjust for interim analyses,3\n307,STUDENT'S T-TEST,A statistical test used to compare the means of two groups,1\n309,WILCOXON'S RANK-SUM TEST,A nonparametric statistical test used to compare two samples,1\n239,H. NJIMI,Trial statistician at Université Libre de Bruxelles in Brussels,1\n98,SALINE VERSUS ALBUMIN FLUID EVALUATION (SAFE) STUDY,\"A double-blind, randomized trial comparing 4% albumin solution with normal saline for fluid replacement in critically ill patients\",2\n99,COCHRANE INJURIES GROUP ALBUMIN REVIEWERS,Published a report in 1998 indicating potential harm in administering albumin to critically ill patients compared to crystalloid solutions,1\n100,CRITICAL ILLNESS,\"A health condition that was the subject of both the ALBIOS and SAFE studies, specifically looking at the administration of fluids in critically ill patients\",1\n337,ELECSYS CORTISOL ASSAY,No Description,1\n333,KLOCKE VERPACKUNGS SERVICE,Company responsible for coding and masking hydrocortisone vials centrally,1\n317,ADMINISTERED TREATMENTS,The treatments given to patients as part of the study protocol,1\n318,HEALTH CARE RESOURCES CONSUMPTION,The use of medical resources and services measured as part of the study's outcomes,1\n19,MARCH 2008,Beginning of patient enrollment for the study,1\n20,AUGUST 2011,End of patient enrollment for the study,1\n118,PERFALGAN,\"Brand of intravenous acetaminophen produced by Bristol-Myers Squibb, used in the ICU study for patients with fever and probable infection\",1\n119,BRISTOL-MYERS SQUIBB,No Description,1\n32,COMITÉ CONSULTATIF DE PROTECTION DES PERSONNES DANS LA RECHERCHE BIOMÉDICALE OF SAINT-GERMAIN EN LAYE,The committee that approved the protocol for the septic shock study,1\n33,SEPTIC SHOCK STUDY,No Description,1\n140,SERUM LACTATE LEVELS,\"A method used for screening for cryptogenic shock in the study\"\"\",1\n152,EMERGENCY DEPARTMENT,No Description,1\n350,FRENCH INTENSIVE CARE SOCIETIES,Recommended fluid resuscitation procedures for the study,1\n351,RICHMOND AGITATION–SEDATION SCALE,\"Scale used to assess sedation levels in patients, ranging from −5 to 4\",1\n63,INDEPENDENT STATISTICIAN,\"A statistician not involved in the trial who performed prespecified interim analyses at certain patient enrollment milestones\"\"\",1\n64,INDEPENDENT DATA MONITORING COMMITTEE,No Description,1\n393,LAN–DEMETS METHOD,A statistical method used for sequential stopping rules for safety and efficacy in clinical trials,1\n394,O'BRIEN–FLEMING APPROACH,A statistical approach used for interim analysis in clinical trials,1\n286,QUALITY-ADJUSTED LIFE-YEARS (QALYS),A measure combining survival data with quality-of-life scores at 90 days used in cost-effectiveness analysis,1\n287,\"STATA/SE SOFTWARE, VERSION 13.0\",Software used for all analyses in the study,1\n260,STUDY SITES,\"34 study sites were involved in screening patients for a study on severe sepsis or septic shock\"\"\",1\n261,SEVERE SEPSIS OR SEPTIC SHOCK,No Description,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n489,ST. ELISABETH HOSPITAL,BELGIUM,St. Elisabeth Hospital is located in Belgium,8\n492,ERASME UNIVERSITY HOSPITAL,BELGIUM,Erasme University Hospital is located in Belgium,7\n495,CENTRE HOSPITALIER UNIVERSITAIRE DE CHARLEROI,BELGIUM,Centre Hospitalier Universitaire de Charleroi is located in Belgium,7\n502,UNIVERSITÉ LIBRE DE BRUXELLES,BELGIUM,Université Libre de Bruxelles is located in Belgium,7\n488,ST. ELISABETH HOSPITAL,BRUSSELS,\"St. Elisabeth Hospital is located in Brussels, Belgium\",7\n491,ERASME UNIVERSITY HOSPITAL,BRUSSELS,\"Erasme University Hospital is located in Brussels, Belgium\",6\n501,UNIVERSITÉ LIBRE DE BRUXELLES,BRUSSELS,\"Université Libre de Bruxelles is located in Brussels, Belgium\",6\n540,ICUS,ROTEXMEDICA,Rotexmedica supplied hydrocortisone used in ICUs for the study,6\n543,ICUS,ROCHE DIAGNOSTICS,Roche Diagnostics' Elecsys cortisol assay was used for cortisol level measurements in the study conducted in ICUs,6\n542,ICUS,ALLIANCE,\"Alliance, like Novartis, provided cosyntropin used in ICUs for corticotropin tests\",5\n508,HYPRESS STUDY,BAG HEALTH CARE GMBH,BAG Health Care GmbH was responsible for producing and releasing the study medication for the HYPRESS study,5\n535,BASE-LINE CHARACTERISTICS,VITAL SIGNS,Base-line characteristics include vital signs among other initial conditions of the patients,5\n536,BASE-LINE CHARACTERISTICS,RESUSCITATION END POINTS,Resuscitation end points were part of the base-line characteristics assessed at the beginning of the study,5\n537,BASE-LINE CHARACTERISTICS,ORGAN-DYSFUNCTION SCORES,Organ-dysfunction scores were included in the base-line characteristics of the patients,5\n538,BASE-LINE CHARACTERISTICS,COAGULATION-RELATED VARIABLES,Coagulation-related variables were assessed as part of the base-line characteristics,5\n507,HYPRESS STUDY,CLINICAL TRIAL CENTRE LEIPZIG,The Clinical Trial Centre Leipzig provides essential services for the HYPRESS study,5\n505,HYPRESS STUDY,GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH,The HYPRESS study is supported by the German Federal Ministry of Education and Research,5\n506,HYPRESS STUDY,GERMAN SEPSIS COMPETENCE NETWORK (SEPNET),The HYPRESS study is conducted in cooperation with the German Sepsis Competence Network,5\n541,ICUS,NOVARTIS,Novartis provided cosyntropin used in ICUs for corticotropin tests,5\n496,J. RICO,RIO HORTEGA UNIVERSITY HOSPITAL,J. Rico is associated with Rio Hortega University Hospital for a medical study,5\n497,J.I. GOMEZ HERRERAS,RIO HORTEGA UNIVERSITY HOSPITAL,J.I. Gomez Herreras is associated with Rio Hortega University Hospital for a medical study,5\n487,ST. ELISABETH HOSPITAL,M. VAN NUFFELEN,M. Van Nuffelen is associated with St. Elisabeth Hospital for a medical study,5\n498,RIO HORTEGA UNIVERSITY HOSPITAL,VALLADOLID,\"Rio Hortega University Hospital is located in Valladolid, Spain\",5\n499,RIO HORTEGA UNIVERSITY HOSPITAL,SPAIN,Rio Hortega University Hospital is located in Spain,5\n486,ST. ELISABETH HOSPITAL,S. BRIMIOULLE,S. Brimioulle is associated with St. Elisabeth Hospital for a medical study,5\n490,ERASME UNIVERSITY HOSPITAL,C. MÉLOT,C. Mélot works at Erasme University Hospital and is responsible for conducting sequential analysis and evaluation of serious adverse effects,4\n494,CENTRE HOSPITALIER UNIVERSITAIRE DE CHARLEROI,CHARLEROI,\"Centre Hospitalier Universitaire de Charleroi is located in Charleroi, Belgium\",4\n493,M. VANCUTSEM,CENTRE HOSPITALIER UNIVERSITAIRE DE CHARLEROI,M. VanCutsem is associated with Centre Hospitalier Universitaire de Charleroi for a medical study,4\n532,CHI-SQUARE TEST,DEMET'S AND LAN,DeMets and Lan's methodology potentially applies to adjustments in analyses involving the Chi-square test,4\n531,STUDENT'S T-TEST,DEMET'S AND LAN,DeMets and Lan's alpha spending function is used alongside statistical tests like Student's T-test for interim analysis adjustments,4\n533,WILCOXON'S RANK-SUM TEST,DEMET'S AND LAN,The alpha spending function by DeMets and Lan could be used to adjust significance levels in analyses involving Wilcoxon's Rank-Sum Test,4\n500,H. NJIMI,UNIVERSITÉ LIBRE DE BRUXELLES,H. Njimi works as a trial statistician at Université Libre de Bruxelles,4\n293,SALINE VERSUS ALBUMIN FLUID EVALUATION (SAFE) STUDY,COCHRANE INJURIES GROUP ALBUMIN REVIEWERS,The SAFE study was conducted in response to concerns raised by the Cochrane Injuries Group Albumin Reviewers about albumin's safety,3\n294,SALINE VERSUS ALBUMIN FLUID EVALUATION (SAFE) STUDY,CRITICAL ILLNESS,The SAFE study investigated fluid replacement with albumin versus saline in critically ill patients,3\n545,ROCHE DIAGNOSTICS,ELECSYS CORTISOL ASSAY,The Elecsys Cortisol Assay is a product developed by Roche Diagnostics for cortisol level measurements,3\n544,ROTEXMEDICA,KLOCKE VERPACKUNGS SERVICE,Klocke Verpackungs Service was responsible for coding and masking vials produced by Rotexmedica,3\n539,ADMINISTERED TREATMENTS,HEALTH CARE RESOURCES CONSUMPTION,The effect of administered treatments on the consumption of health care resources was examined,2\n129,MARCH 2008,AUGUST 2011,Patient enrollment period for the study spanned from March 2008 to August 2011,2\n330,PERFALGAN,BRISTOL-MYERS SQUIBB,Perfalgan is produced by Bristol-Myers Squibb and was used in the study on acetaminophen's effects in ICU patients,2\n191,COMITÉ CONSULTATIF DE PROTECTION DES PERSONNES DANS LA RECHERCHE BIOMÉDICALE OF SAINT-GERMAIN EN LAYE,SEPTIC SHOCK STUDY,The committee approved the protocol for the septic shock study,2\n360,SERUM LACTATE LEVELS,EMERGENCY DEPARTMENT,Serum lactate levels were measured in the emergency department as part of the screening for cryptogenic shock,2\n552,FRENCH INTENSIVE CARE SOCIETIES,RICHMOND AGITATION–SEDATION SCALE,The societies recommended procedures that include the use of the Richmond Agitation–Sedation Scale,2\n248,INDEPENDENT STATISTICIAN,INDEPENDENT DATA MONITORING COMMITTEE,The independent statistician conducted interim analyses that were reviewed by the Independent Data Monitoring Committee,2\n576,LAN–DEMETS METHOD,O'BRIEN–FLEMING APPROACH,Both statistical methods were used for interim analysis and sequential stopping rules in the clinical trial,2\n527,QUALITY-ADJUSTED LIFE-YEARS (QALYS),\"STATA/SE SOFTWARE, VERSION 13.0\",The software was used for analyses including the calculation of QALYs,2\n513,STUDY SITES,SEVERE SEPSIS OR SEPTIC SHOCK,Study sites were involved in a study focusing on severe sepsis or septic shock,2\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}